Histamine H₃ receptor activation normalizes thalamic GABA release and attenuates dyskinesias while preserving the L-Dopa antiparkinsonian effect in 6-hydroxydopamine-lesioned rats
Publication date: Available online 17 November 2026 Source: Brain Research Bulletin Author(s): Alexander Aguirre-Pérez, Alberto Avila-Luna, Antonio Verduzco-Mendoza, Silvia-Adriana Olmos-Hernández, Arturo Gálvez-Rosas, Laura Sánchez-Chapul, Francisca Pérez-Severiano, Paul Carrillo-Mora, Camilo Ríos, Betzabeth García-Martínez, Carmen Parra-Cid, José-Antonio Arias-Montaño, Antonio Bueno-Nava
Histamine H₃ receptor activation normalizes thalamic GABA release and attenuates dyskinesias while preserving the L-Dopa antiparkinsonian effect in 6-hydroxydopamine-lesioned rats. // American Journal of Pharmaceutical Education. – URL: https://www.sciencedirect.com/science/article/pii/S0361923026005125?dgcid=rss_sd_all
Histamine H₃ receptor activation normalizes thalamic GABA release and attenuates dyskinesias while preserving the L-Dopa antiparkinsonian effect in 6-hydroxydopamine-lesioned rats. American Journal of Pharmaceutical Education. https://www.sciencedirect.com/science/article/pii/S0361923026005125?dgcid=rss_sd_all
“Histamine H₃ receptor activation normalizes thalamic GABA release and attenuates dyskinesias while preserving the L-Dopa antiparkinsonian effect in 6-hydroxydopamine-lesioned rats.” American Journal of Pharmaceutical Education.
@article{article13652,
title = {Histamine H₃ receptor activation normalizes thalamic GABA release and attenuates dyskinesias while preserving the L-Dopa antiparkinsonian effect in 6-hydroxydopamine-lesioned rats},
journal = {American Journal of Pharmaceutical Education},
url = {https://www.sciencedirect.com/science/article/pii/S0361923026005125?dgcid=rss_sd_all}
}